Discover Tenders by Pharmaceuticals Sector

Healthcare and Medical Pharma Procurement Opportunities: Explore the most recent tender notices for thousands of Healthcare and Medical Pharma eTenders, eProcurement Notices, Bids, Updates, and more. Conduct searches for both Government and Private Healthcare and Medical Pharma Tenders published on various tender and eProcurement portals worldwide.

Filter Your Search

Country

Sector

Region

Funding Agency

Open House Drug Discount Agreements For The Active Ingredient Adalimumab Atc L0

Deadline: 31 Jan 2028

Germany

Ref. No.: 24889126

EMD:Ref Document

Bid Value: Ref Document

548 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A

Deadline: 26 Jan 2028

Germany

Ref. No.: 24877039

EMD:Ref Document

Bid Value: Ref Document

543 Days Left

Medicines With The Active Ingredient Combination Sofosbuvir And Velpatasvir Atc

Deadline: 31 Jan 2028

Germany

Ref. No.: 24874241

EMD:Ref Document

Bid Value: Ref Document

548 Days Left

Open House Drug Discount Agreements For The Active Ingredient Adalimumab Atc L0

Deadline: 01 Feb 2028

Germany

Ref. No.: 24869480

EMD:Ref Document

Bid Value: Ref Document

549 Days Left

Open House Drug Discount Agreements For The Active Ingredient Infliximab Atc L0

Deadline: 01 Feb 2028

Germany

Ref. No.: 24869141

EMD:Ref Document

Bid Value: Ref Document

549 Days Left

Open House Drug Discount Agreements In Accordance With Section 130A Paragraph 8C

Deadline: 21 Feb 2027

Germany

Ref. No.: 24865814

EMD:Ref Document

Bid Value: Ref Document

204 Days Left

Open House Pharmaceutical Discount Contracts In Accordance With Section 130A Par

Deadline: 21 Feb 2027

Germany

Ref. No.: 24863151

EMD:Ref Document

Bid Value: Ref Document

204 Days Left

Drug Discount Agreements From April 1 2026 On Various Active Ingredients As Par

Deadline: 04 Feb 2028

Germany

Ref. No.: 24862587

EMD:Ref Document

Bid Value: Ref Document

552 Days Left

Open House Drug Discount Agreements For The Active Ingredient Infliximab Atc L0

Deadline: 31 Jan 2028

Germany

Ref. No.: 24862114

EMD:Ref Document

Bid Value: Ref Document

548 Days Left

Market For The Purchase Of Raw Materials For Pharmaceutical Use The Development

Deadline: 15 Feb 2038

France

Ref. No.: 24859154

EMD:Ref Document

Bid Value: Ref Document

4216 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A

Deadline: 31 Dec 2026

Germany

Ref. No.: 24858495

EMD:Ref Document

Bid Value: Ref Document

152 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A

Deadline: 31 Dec 2026

Germany

Ref. No.: 24857603

EMD:Ref Document

Bid Value: Ref Document

152 Days Left

Trastuzumab Atc L01Fd01

Deadline: 22 Feb 2027

Germany

Ref. No.: 24856208

EMD:Ref Document

Bid Value: Ref Document

205 Days Left

Rituximab Atc L01Fa01

Deadline: 22 Feb 2027

Germany

Ref. No.: 24856196

EMD:Ref Document

Bid Value: Ref Document

205 Days Left

Bevacizumab Atc L01Fg01

Deadline: 22 Feb 2027

Germany

Ref. No.: 24856189

EMD:Ref Document

Bid Value: Ref Document

205 Days Left

Showing 7486 to 7500 of 8926 results

Discover Tenders by Pharmaceuticals Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Pharmaceuticals Sector

Filter Your Search

FREE Trial plan for all new users!